Evidence map›Paper›PMID 32648063›Full record

ArticleAIDS and behavior2021

Combination HIV Prevention Strategies Among Montreal Gay, Bisexual, and Other Men Who Have Sex with Men in the PrEP Era: A Latent Class Analysis.

Carla M Doyle, Mathieu Maheu-Giroux, Gilles Lambert, Sharmistha Mishra, Herak Apelian, Marc Messier-Peet, Joanne Otis, Daniel Grace, Trevor A Hart, David M Moore and 3 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Carla M DoyleDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0001-5104-3068
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Gilles LambertDirection Régionale de Santé Publique de Montréal, Montreal, QC, Canada.
Sharmistha MishraDepartment of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Herak ApelianDirection Régionale de Santé Publique de Montréal, Montreal, QC, Canada.
Marc Messier-PeetDirection Régionale de Santé Publique de Montréal, Montreal, QC, Canada.
Joanne OtisDépartement de Sexologie, Université du Québec à Montréal, Montreal, QC, Canada.
Daniel GraceDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Trevor A HartDepartment of Psychology, Ryerson University, Toronto, ON, Canada.
David M MooreBC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Nathan J LachowskySchool of Public Health and Social Policy, University of Victoria, Victoria, BC, Canada.
Joseph CoxDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada. joseph.cox@mcgill.ca.ORCID http://orcid.org/0000-0002-7041-1556
Engage Study Team
McGill University · CAMcGill University Health Centre · CAPublic Health Ontario · CASt. Michael's Hospital · CAUniversité du Québec à Montréal · CAUniversity of British Columbia · CAUniversity of Toronto · CAUniversity of Victoria · CA

Funding

Canadian Blood Services #MSM2017LP-ODCanadian Foundation for AIDS Research #EngageCanadian HIV Trials Network, Canadian Institutes of Health Research #CTN300CIHR #TE2-138299Michael Smith Foundation for Health Research #16863Ontario HIV Treatment Network #1051Public Health Agency of Canada 4500370314
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) became publicly available in Quebec for gay, bisexual and other men who have sex with men (GBM) in 2013. We used baseline data from Engage, a cohort of GBM recruited by respondent-driven sampling, to examine patterns of combination HIV prevention use among Montreal GBM since PrEP became available. Latent class analysis, stratified by HIV status, was used to categorize GBM by self-reported use of biomedical and behavioural prevention strategies. Correlates of resulting classes were identified using multinomial logistic regression. Among HIV-negative/unknown GBM (n = 968), we identified four classes: low use of prevention (32%), condoms (40%), seroadaptive behaviour (21%), and biomedical (including PrEP; 7%). Those using prevention (condoms, seroadaptive behaviour, and biomedical) had a higher number of anal sex partners and were more likely to report a recent sexually transmitted infection diagnosis. GBM using biomedical prevention also had a higher level of formal education. Among GBM living with HIV (n = 200), we identified three classes: mainly antiretroviral treatment (ART) with viral suppression (53%), ART with viral suppression and condoms (19%), and ART with viral suppression and seroadaptive behaviour (18%). Again, the number of anal sex partners was higher among those using condoms and seroadaptive behaviours. Our findings show antiretroviral-based prevention, either alone or in combination with other strategies, is clearly a component of the HIV prevention landscape for GBM in Montreal. Nevertheless, PrEP uptake remains low, and there is a need to promote its availability more widely.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexual BehaviorBisexualityHomosexualityHomosexuality, MaleHumansLatent Class AnalysisMaleQuebecCombination HIV preventionHIV prevention strategiesLatent class analysisMen who have sex with menPre-exposure prophylaxis

Identifiers

PMID32648063
PMCPMC7846508
OpenAlexW3040781874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.